Women's Hospital School of Medicine Zhejiang University
Hangzhou, Zhejiang, 310006, China
Location status: Recruiting
Location contact
Dan Zhang, Ph. D.
PRINCIPAL_INVESTIGATOR
Huajing Gao, MD Candidate
CONTACT
86+18867114750
NCT Number: NCT07082530
The investigators are committed to identifying the optimal timing of delivery for low-risk pregnancies. While current guidelines typically recommend induction at 41 weeks, emerging evidence suggests that elective induction at 39 weeks may lead to improved maternal and neonatal outcomes. The U.S.-based ARRIVE trial demonstrated that induction at 39 weeks significantly reduced cesarean delivery rates compared to expectant management, and a similar randomized controlled trial (French-ARRIVE) is ongoing in France. However, population-specific evidence for the Chinese population remains lacking.
This study is designed to establish a prospective cohort of low-risk pregnant women in China, comparing the effects of induction at 39 weeks, induction at 41 weeks, and expectant management on cesarean section rates and other maternal and neonatal outcomes. In addition, multi-omics technologies will be employed to analyze cord blood samples-including metabolomics and proteomics-to identify early biomarkers potentially associated with long-term child health. The study will begin with a pilot phase to assess feasibility and inform operational strategies for large-scale implementation.
The ultimate goal of this project is to generate evidence tailored to the Chinese population to support more individualized decision-making, improve clinical outcomes, and enhance maternal and neonatal safety.
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
Hangzhou, Zhejiang, 310006, China
Location status: Recruiting
Dan Zhang, Ph. D.
PRINCIPAL_INVESTIGATOR
Huajing Gao, MD Candidate
CONTACT
86+18867114750
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Labor induction at 39 weeks 0 days to 39 weeks 4 days
Expectant management until spontaneous labor or induction at 41 weeks.
Time frame: Delivery day
The proportion of deliveries completed by cesarean section
Time frame: Hospital discharge (Day 2-3)
The composite incidence of any of the following:
Time frame: Delivery day
Cesarean delivery performed immediately or shortly after clinical decision due to imminent threat to the life of the mother or fetus
Time frame: Delivery day
Cesarean performed within approximately 30 minutes due to immediate life-threatening conditions (e.g., uterine rupture, severe fetal distress)
Time frame: Delivery day
Cesarean performed within 60-75 minutes due to urgent but not immediately life-threatening indications (e.g., progressive fetal distress, labor arrest)
Time frame: Delivery day
Planned cesarean performed at or after 39 weeks in the absence of emergency conditions, meeting all of the following:
Time frame: Delivery day
The rate of vaginal deliveries assisted with instruments such as forceps or vacuum.
Time frame: Delivery day
Expressed in weeks and decimal days (e.g., 39 weeks + 5 days = 39.7 weeks)
Time frame: Delivery day
Incidence of chorioamnionitis, defined as a clinical diagnosis before delivery as: maternal body temperature rises (>38°C) with 2 or more of the following symptoms:
Time frame: Delivery day
The incidence of third-or fourth-degree perineal laceration
Time frame: Hospital discharge (Day 2-3)
Refer to the ARRIVE cohort, defined as any of the following situations:
Time frame: Hospital discharge (Day 2-3)
Refer to the ARRIVE cohort, defined as any of the following situations:
Time frame: Hospital discharge (Day 2-3)
The proportion of admission to the ICU
Time frame: Hospital discharge (Day 2-3)
The incidence of maternal death
Time frame: Hospital discharge (Day 2-3)
The incidence of preeclampsia or gestational hypertension diagnosed during labor
Time frame: Hospital discharge (Day 2-3)
Deep vein thrombosis or pulmonary embolism
Time frame: Hospital discharge (Day 2-3)
Median patient-reported pain outcomes with a 10-point Likert scale
Time frame: Delivery day
The mean birth weight
Time frame: Delivery day
The proportion of female offspring in terms of physiological gender
Time frame: Delivery day
Birth weight > 4000g
Time frame: Delivery day
According to the infant's gender and gestational age, the birth weight exceeds the 90th percentile of infants of the same gestational age
Time frame: Delivery day
According to the infant's gender and gestational age, the birth weight is less than the 10th percentile of infants of the same gestational age
Time frame: Delivery day
Apgar score at 5 minutes after birth
Time frame: Delivery day
The incidence of neonatal acidosis defined as umbilical artery blood pH < 7.10
Time frame: Delivery day
The incidence of shoulder dystocia
Time frame: Hospital discharge (Day 2-3)
The incidence of hyperbilirubinemia requiring phototherapy or exchange transfusion
Time frame: Hospital discharge (Day 2-3)
The incidence of neonatal transfusion of blood products or blood
Time frame: Hospital discharge (Day 2-3)
The incidence of hypoglycemia (blood glucose < 35mg/L) requiring intravenous treatment
Time frame: Hospital discharge (Day 2-3)
The incidence of admission to the NICU lasting more than 48 hours
Time frame: 6 weeks and 6 months
Infant weight, length, head circumference, chest circumference, sitting height, upper arm circumference, subcutaneous fat, height-chest circumference index, crown-rump length/length
Time frame: 6 weeks and 6 months
Weight-for-length, length-for-age, weight-for-age z scores of infants, calculated using the World Health Organization (WHO) tool, WHO Anthro Survey Analyser
Time frame: 6 weeks and 6 months
Height standard deviation for age < mean-2S or percentile method < P3
Time frame: 6 weeks and 6 months
The proportion of abnormal results in neurological examinations (hearing development, nerve reflexes)
Time frame: 6 weeks and 6 months
Total score, cognitive scale score, language scale score, motor scale score, social-emotional scale score, adaptive behavior scale score
Time frame: 6 weeks and 6 months
Total score, communication domain score, gross motor domain score, fine motor domain score, problem-solving domain score, personal-social domain score
Time frame: 6 weeks and 6 months
Allergic diseases diagnosed by neonatologists, including cow's milk allergy, allergic rhinitis, eczema/allergic dermatitis, asthma, wheezing and other allergic disorders
Time frame: Delivery day
Median time from randomization to birth of the fetus, measured in hours
Time frame: Delivery day
Rate of epidural analgesia use
Time frame: Hospital discharge (Day 2-3)
Median maternal hospital stays, measured in hours
Time frame: Hospital discharge (Day 2-3)
Median neonatal hospital stays, measured in hours
Time frame: Hospital discharge (Day 2-3)
Total hospitalization cost during delivery, before insurance reimbursement
Time frame: Hospital discharge (Day 2-3)
Out-of-pocket cost incurred during delivery hospitalization
Time frame: Meconium, first 48 hours, 7 days, 3 weeks, 6 weeks, 3 months, and 6 months
Microbiota richness, dominant species, species transferred from mother to child, sub-group functional trajectory changes of the dominant species in offspring, and the transmissibility of species number and function
Time frame: Meconium, first 48 hours, 7 days, 3 weeks, 6 weeks, 3 months, and 6 months
Non-targeted metabolomic macroscopic differences, core metabolomic differences (including tryptophan, fatty acids), and differences in gut microbiota metabolites
Time frame: Delivery day
Assessment of non-targeted metabolomic macroscopic differences and core metabolomic differences (including tryptophan, fatty acids) in cord blood plasma
Time frame: Delivery day
Analysis of the proteomic characteristics of cord blood whole blood to trace back the health status during the fetal period
Contact information is provided by the study sponsor or research team.
Women's Hospital School Of Medicine Zhejiang University
Other
Labor Induction in Low-risk Women at 39 Weeks of Gestation: A Randomized Trial in China
Acronym: LIRIC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07362992
Blood Loss, Surgical, Cesarean Delivery
Holon, Central District, Israel
View Trial DetailsNCT06030063
Cesarean Delivery, General Anesthesia
Little Rock, Arkansas, United States
View Trial DetailsNCT07326644
Body Weight, Body Weight Changes
Elâzığ, Elaziğ, Turkey (Türkiye)
View Trial DetailsNCT07019623
Balloon, Cesarean Delivery
Zurich, Switzerland
View Trial Details